288330 — Bridge Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Bridge Biotherapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	57,943	43,128	51,295	20,183	21,763
Net Total Accounts Receivable
Net Total Receivables	1,797	415	987	856	693
Prepaid Expenses
Total Other Current Assets
Total Current Assets	60,304	44,426	54,957	21,731	23,360
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	830	664	3,784	4,287	3,037
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	63,510	46,657	61,455	34,222	33,492
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,055	3,556	7,494	10,375	3,875
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	4,282	3,610	9,590	14,845	7,246
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	59,228	43,047	51,865	19,377	26,246
Total Liabilities & Shareholders' Equity	63,510	46,657	61,455	34,222	33,492
Total Common Shares Outstanding
Total Preferred Shares Outstanding